Total tumor volume as a predictor of survival in patients with multiple oligometastases treated with stereotactic ablative radiotherapy (SABR)

被引：0
|
作者：
Ciro Franzese
Veronica Vernier
Davide Franceschini
Tiziana Comito
Pierina Navarria
Elena Clerici
Maria Ausilia Teriaca
Maria Massaro
Luciana Di Cristina
Beatrice Marini
Carmela Galdieri
Pietro Mancosu
Stefano Tomatis
Marta Scorsetti
机构：
[1] Humanitas University,Department of Biomedical Sciences
[2] IRCCS Humanitas Research Hospital,Department of Radiotherapy and Radiosurgery
来源：
Journal of Cancer Research and Clinical Oncology | 2023年 / 149卷
关键词：
Oligometastatic; SBRT; SABR; Stereotactic radiotherapy; Oligometastases; Multiple; Radiosurgery; Stereotactic ablative radiotherapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：10495 / 10503
页数：8
相关论文
共 50 条
  • [21] Stereotactic ablative body radiotherapy (SABR) for multiple lung tumours: hazardous or harmless?
    Allos, B.
    Carruthers, H.
    Harrop, V.
    Stange, D.
    Misheva, T.
    Stevenson, R.
    Watkins, S.
    Ghafoor, Q.
    LUNG CANCER, 2018, 115 : S58 - S58
  • [22] Efficacy and safety profile of Stereotactic Ablative Radiotherapy (SABR) for multiple lung primaries
    Littlejohns, A.
    Janjua, T.
    Murray, P.
    Jain, P.
    Clarke, K.
    Dickinson, P.
    Teo, M.
    Saha, A.
    Franks, K.
    Sun, F.
    RADIOTHERAPY AND ONCOLOGY, 2020, 152 : S542 - S542
  • [23] TREATMENT OF MULTIPLE PRIMARY LUNG CANCERS (MPLC) WITH STEREOTACTIC ABLATIVE RADIOTHERAPY (SABR)
    Griffioen, Gwendolyn H.
    Lagerwaard, Frank
    Haasbeek, Cornelis J.
    Smit, Egbert
    Slotman, Ben J.
    Senan, Suresh
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S839 - S839
  • [24] Comparison of survival and prognostic factors in patients treated with stereotactic body radiotherapy for oligometastases or oligoprogression
    Pembroke, Catherine A.
    Fortin, Bernard
    Kopek, Neil
    RADIOTHERAPY AND ONCOLOGY, 2018, 127 (03) : 493 - 500
  • [25] Stereotactic Ablative Radiotherapy (SABR) for Prostate Cancer - an Analysis of 500 Consecutive Patients Treated at a Single Institution
    Miszczyk, L.
    Namysl-Kaletka, A. J.
    Napieralska, A.
    Kraszkiewicz, M.
    Miszczyk, M.
    Wozniak, G.
    Stapor-Fudzinska, M.
    Glowacki, G.
    Tukiendorf, A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : E295 - E295
  • [26] Optimization and Evaluation of Dynamic Wave Arc Trajectory Radiotherapy for Patients Treated on a Dedicated Stereotactic Ablative Radiotherapy (SABR) system
    Pourmoghaddas, Amir
    Bergman, Alanah M.
    MEDICAL PHYSICS, 2019, 46 (11) : 5400 - 5400
  • [27] Survival and prognostic factors of pulmonary oligometastases treated with stereotactic body radiotherapy
    Sharma, Aman
    Duijm, Marloes
    Oomen-de Hoop, Esther
    Aerts, Joachim G.
    Verhoef, Cornelis
    Hoogeman, Mischa
    Nuyttens, Joost Jan
    ACTA ONCOLOGICA, 2019, 58 (01) : 74 - 80
  • [28] Should We be Offering Our Patients With Oligometastases Stereotactic Ablative Body Radiotherapy?
    Ostler, P.
    Hoskin, P.
    Martin, A.
    CLINICAL ONCOLOGY, 2021, 33 (12) : 747 - 748
  • [29] Toxicities and Survival after Stereotactic Ablative Radiotherapy (SABR) for Centrally Located Lung Tumors
    Atalar, B.
    Mustafayev, T.
    Sio, T.
    Sahin, B.
    Gungor, G.
    Aydin, G.
    Yapici, B.
    Ozyar, E.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S836 - S837
  • [30] POPULATION BASED PHASE II TRIAL OF STEREOTACTIC ABLATIVE RADIOTHERAPY (SABR) FOR UP TO FIVE OLIGOMETASTASES: PRELIMINARY RESULTS OF THE SABR-5 TRIAL
    Olson, Robert
    Jiang, Will
    Liu, Mitchell
    Bergman, Alanah
    Schellenberg, Devin
    Mou, Benjamin
    Alexander, Abraham
    Carolan, Hannah
    Hsu, Fred
    Miller, Stacy
    Atrchian, Siavash
    Chan, Elisa
    Ho, Clement
    Mohamed, Islam
    Lin, Angela
    Berrang, Tanya
    Bang, Andrew
    Chng, Nick
    Matthews, Quinn
    Mestrovic, Ante
    Hyde, Derek
    Huang, Vicky
    Lund, Chad
    Pai, Howard
    Valev, Boris
    Lefresne, Shilo
    Tyldesley, Scott
    RADIOTHERAPY AND ONCOLOGY, 2021, 163 : S4 - S4
12345